Article Sidebar

Download
PDF (Français)

Main Article Content

Abstract

RÉSUMÉ
Objectif. Déterminer la fréquence des facteurs de risque cardiovasculaire (FRCV) chez des patients bénéficiant d’une chirurgie urologique à Ngaoundéré au Cameroun. Population et méthodes. Une étude transversale a été conduite au service de chirurgie urologique de la clinique islamique de Ngaoundéré au Cameroun. Les données sociodémographiques, cliniques et biologiques ont été collectées chez les patients qui y étaient admis pour une intervention urologique et analysées à l’aide du logiciel Sphinx V5. Résultats. Au total, 58 patients ont participé à l’étude.  Les fréquences de l’obésité, du surpoids, du diabète, de l’hypertension artérielle, et de la sédentarité étaient respectivement de 3,4%, 17,2%, 19%, 24,1%, et 39,7%. La prévalence des taux élevés de triglycérides, de cholestérol total, et de cholestérol Low Density Lipoprotein (LDL) était respectivement de 1,7%, 8,60% et de 29,3% celle des taux faibles de cholestérol High Density Lipoprotein (HDL) était de 29,3%. L’allongement du séjour post opératoire était la complication la plus fréquente (70,9 %). Elle était significativement liée à l’hypertension artérielle (p < 0,034). Conclusion. Ce travail révèle une prévalence élevée de l’hypertension artérielle, du diabète, de la sédentarité, des taux faibles de cholestérol LDL et des taux élevés de cholestérol HD L dans la population étudiée.

ABSTRACT
Objective. To determine frequency of cardiovascular risk factors in patients undergoing urological surgery in Ngaounderé, Cameroon. Population and methods. A cross-sectional study was conducted in the urological surgery department of Ngaoundere islamic clinic in Cameroun. Sociodemographic, clinical and biological data were collected from patients admitted for urological surgery and analyzed using Sphinx V5 software. Results. A total of 58 patients took part in the study. Frequencies of obesity, overweight, diabetes, high blood pressure and physical inactivity were 3.40%, 17.20%, 19%, 24.10%, and 39.7% respectively. Prevalence rates of high levels of triglycerides, total cholesterol, and LDL cholesterol were l. 7 %, 8.60 % and 29.3% respectively. Delay of the post-operative hospitalization was the most frequent post-operative complication (70.91%). It was significantly associated with high blood pressure (p <0.034). Conclusion. The study reveals a high prevalence of high blood pressure, diabetes, physical inactivity, high serum LDL cholesterol and low serum HDL in the study population.

Article Details

How to Cite
Pancha, M. O., Ngangao, H., Ngoufack, T., Ndanki, F., & Eloundou, N. (2020). Facteurs de Risque Cardiovasculaire en Chirurgie Urologique à Ngaoundéré (Cameroun). HEALTH SCIENCES AND DISEASE, 21(8). https://doi.org/10.5281/hsd.v21i8.2196
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Kasliwal RR, Kulshreshtha A, Agrawal S, Bansal M, Trehan N. Prevalence of cardiovascular risk factors in Indian patients undergoing coronary artery bypass surgery. J Assoc Physicians India 2006; 54:371–375.
  2. Mangano DT. Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth 2004; 18:1-6.
  3. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-184.
  4. Campeau L, Enjalbert M, Lespérance J, Bourassa M, Kwiterovich P, Wacholder S et coll.The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation: A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984; 311:1329-32.
  5. Poldermans D, Bax JJ, Boersma E, et coll.Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769-812.
  6. Knatterud G, Rosenberg Y, Campeau L, Geller. L, Hunninghake D, Forman S et coll. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 2000; 102:157-65.
  7. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM M et coll. European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2012; 33: 1635-1701.
  8. OMS. Le Manuel de Surveillance STEPS de l’OMS : L'approche STEPwise de l'OMS pour la surveillance des facteurs de risque des maladies chroniques. Genève, Organisation Mondiale de la Santé 2005 ; 453.
  9. Eknoyan G. Adolphe Quetelet. The average man and indices of obesity. Historical Note. Nephrol Dial Transplant 2008; 23: 47–51.
  10. Pancha OM, Damdam FB, Tamanji MT. Comparison of lipid profiles and 10 years cardiovascular disease risk estimates between indigenous northern diabetic and non-diabetic persons in Adamawa region, Cameroon. Journal of Medical and Biomedical Sciences 2015; 4:18-24.
  11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol plasma without use of ultracentrifuge. Clinical Chemistry, 1972; 18: 499-502.
  12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et coll. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560-72.
  13. Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA, Howard J et coll.Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Circulation 2002; 106 (25): 3143. 16
  14. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
  15. WHO STEPS Instrument Question-by-Question Guide (Core and Expanded), The WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS). Geneva 27, Switzerland, World Health Organization, disponible sur: www.who.int/ncds/ steps, consulté le 15/08/2019. 12
  16. WHO Global status report on alcohol and health 2018.Geneva, Switzerland, World Health Organization 2018; 14-15. 13
  17. Global Adult Tobacco Survey Collaborative Group. Questions sur le tabagisme à utiliser dans les enquêtes : sous-ensemble de questions essentielles tirées de l’enquête mondiale sur le tabagisme chez les adultes (GATS), 2e édition. Atlanta, GA: Centers for Disease Control and Prevention 2011. 14
  18. Bongard V, Ferrières J. Facteurs de risque cardiovasculaire et prévention. La revue du praticien 2006 ; 56 : 79-87.
  19. Moor VJA, Amougou SN, Ombotto S, Ntone F, Wouamba DE, Ngo Nonga B. Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaoundé, Cameroon. International Journal of Vascular Medicine 2017 ; 6061306. Doi : 10.1155/2017/6061306, consulté le 15/07/2019.
  20. Madika A-L, Mounier-Vehier C. Tabac et pression artérielle : une relation complexe à mieux connaître. La Presse Médicale 2017; 46 (7-8): 697-702.
  21. Waly HM, Elayda MA, Lee VV, el-Said G, Reul GJ, Hall RJ. Risk factor analysis among Egyptian patients who underwent coronary artery bypass surgery. Tex Heart Inst J 1997; 24: 204-208.
  22. INS. Enquête mondiale sur le tabagisme chez les adultes, Rapport principal. Yaoundé, Cameroun. Institut National de la Statistique, 2013.
  23. Guignard R, Beck F, Richard J-B, Peretti-Watel P. Le tabagisme en France : analyse de l’enquête Baromètre santé 2010. Saint-Denis, Inpes, coll. Baromètres santé, 2013 : 56 p.
  24. Ndekouong K, Ngwa E, Nketcha N. Lutte contre le tabagisme au Cameroun, Pour une augmentation des taxes sur les cigarettes. Avec le Soutien du CRDI. Ottawa, Canada 2012; 4. www.who.int/tobacco/framework/WHO_FCTC_french.pdf, consulté le 25/04/2018.
  25. Nashef SA, Roques F, Michel P, Cortina J, Faichney A, Gams E, Harjula A, Jones MT. Coronary surgery in Europe: comparison of the national subsets of the European system for cardiac operative risk evaluation database. Eur J Cardiothorac Surg 2000; 17(4):396-9.
  26. Kingue S, Ngoe CN, Menanga AP, Jingi AM, Noubiap JJN, Fesuh B et al. Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population based cross sectional study. The Journal of Clinical Hypertension 2015; 17(10), 819-824.
  27. Asghari G, Mirmiran P, Hosseni-Esfahani F, Nazeri P, Mehran M, Azizi F. Dietary Quality among Tehranian Adults in Relation to Lipid Profile: Findings from the Tehran Lipid and Glucose Study. J Health Popul Nutr 2013; 31(1): 37-48.
  28. Fleisher LA1, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):e418-99.

Similar Articles

You may also start an advanced similarity search for this article.